论文部分内容阅读
对子宫内膜癌多数采用手术及放射治疗。尽管多数晚期的病例仍限于局部或不同程度扩散到区域淋巴结,但已扩散的及复发的病例其治愈率是很低的。用孕激素的辅助治疗有30～50%病例可收到客观疗效。面对非激素化疗效果则估计甚少。一些抗肿瘤药物单独应用可收到部分效果,而联合化疗则比单一用药更有效。本文主要是探讨联合用药对晚期子宫内膜癌之效果。本组病人包括10例扩散的子宫内膜癌及10例复发病例。若癌肿仅限于宫内开始的治疗包括术前后负荷技术的宫腔镭疗,子宫全切(I期)或根治性子宫切除(I期)伴双附件切除。对癌细胞分化良好,无峡部及宫颈浸润,无子宫肌层或浅表肌层浸
The majority of endometrial cancer surgery and radiation therapy. Although most of the advanced cases are still limited to local or different degree of spread to the regional lymph nodes, but the proliferation and recurrence of the cure rate is very low. With progesterone adjuvant therapy 30 to 50% of cases received objective effects. The face of non-hormonal chemotherapy is estimated very little. Some antineoplastic drugs can receive some effects alone, while combination chemotherapy is more effective than a single drug. This article is mainly to explore the effect of combination therapy on advanced endometrial cancer. The group of patients, including 10 cases of diffuse endometrial cancer and 10 cases of recurrence. If the cancer is limited to intrauterine treatment including intrauterine radiotherapy of preoperative and postoperative loading techniques, total hysterectomy (stage I) or radical hysterectomy (stage I) with double attachment excision. Good differentiation of cancer cells, no isthmus and cervical infiltration, no myometrial or superficial myometrial immersion